Page last updated: 2024-11-01

nialamide and Cardiomyopathies

nialamide has been researched along with Cardiomyopathies in 1 studies

Nialamide: An MAO inhibitor that is used as an antidepressive agent.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chekunova, MP1
Suvorov, IM1
Zenkevich, ES1
Chekodanova, NV1
Minkina, NA1

Other Studies

1 other study available for nialamide and Cardiomyopathies

ArticleYear
[Pathogenetic therapy of cobalt-induced cardiomyopathies].
    Kardiologiia, 1980, Volume: 20, Issue:11

    Topics: Adrenergic beta-Antagonists; Anabolic Agents; Animals; Cardiomyopathies; Cobalt; Drug Evaluation, Pr

1980